Browse by author
Lookup NU author(s): Professor Colin Rees, Professor Linda Sharp, Dr Sara Koo
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020, Springer Nature Limited.Population screening and endoscopic surveillance are used widely to prevent the development of and death from colorectal cancer (CRC). However, CRC remains a major cause of cancer mortality and the increasing burden of endoscopic investigations threatens to overwhelm some health services. This Perspective describes the rationale for and approach to improved risk stratification and decision-making for CRC prevention and diagnosis. Limitations of current approaches will be discussed using the UK as an example of the challenges faced by a particular health-care system, followed by discussion of novel risk biomarker utilization. We explore how risk stratification will be advantageous to current health-care providers and users, enabling more efficient use of limited colonoscopy resources. We discuss risk stratification in the setting of population screening as well as the surveillance of high-risk groups and investigation of symptomatic patients. We also address challenges in the development and validation of risk stratification tools and identify key research priorities.
Author(s): Hull MA, Rees CJ, Sharp L, Koo S
Publication type: Review
Publication status: Published
Journal: Nature Reviews Gastroenterology and Hepatology
Year: 2020
Volume: 17
Pages: 773-780
Print publication date: 01/12/2020
Online publication date: 16/10/2020
Acceptance date: 08/09/2020
ISSN (print): 1759-5045
ISSN (electronic): 1759-5053
Publisher: Nature Research
URL: https://doi.org/10.1038/s41575-020-00368-3
DOI: 10.1038/s41575-020-00368-3
